Sponsor:
Tela Bio Inc
Code:
NCT07070115
Conditions
Hiatal Hernia
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
OviTex Reinforced Tissue Matrix
Brief summary:
Conditions
Hiatal Hernia
Study ID
NCT07070115
Start date
Jul 25, 2025
Status verified date
Feb, 2026
Completion date
Jul 31, 2032
Anticipated
Primary completion date
Dec 31, 2031
Anticipated
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Enrollment
173 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
other: OviTex Reinforced Tissue Matrix
Interventions
OviTex Reinforced Tissue Matrix
Primary outcome measure
Central contacts
Locations
University of South Alabama Health
Recruiting
Mobile, Alabama, United States, 36617
Contacts
Principal Investigator:
William O Richards, MD
SurgOne, PC
Recruiting
Denver, Colorado, United States, 80210
Contacts
Principal Investigator:
Ahmed Zihni, MD
University of Kentucky
Recruiting
Lexington, Kentucky, United States, 40536
Contacts
Principal Investigator:
J. Scott Roth, MD
Wake Forest University Health Sciences
Recruiting
Charlotte, North Carolina, United States, 28204
Contacts
Principal Investigator:
Paul Colavita, MD
The University of Texas at Austin - Dell Medical School
Recruiting
Austin, Texas, United States, 78712
Contacts
Principal Investigator:
F.P. Tripp Buckley III, MD, FACS, FAFS
Sponsor
Tela Bio Inc
Last update posted
Aug 18, 2026
Last verified
Feb, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Tela Bio Inc on 2026-08-18.